Lights…Camera… Action.
October 19, 2026 Bonus Content: Google’s 702MW Fuel-Cell Deal Puts Bloom Energy Center Stage A...
October 19, 2026 Bonus Content: Google’s 702MW Fuel-Cell Deal Puts Bloom Energy Center Stage A...
Centinela strike ends. With the premium fading, FCX and ANTO face a different test at the open.
With Moody's putting the real private credit default rate at 5.8% and AI debt markets wobbling, Thursday's earnings call is…
October 18, 2026 Bonus Content: Opko Health Sold Its Last Diagnostics Asset. What’s Left? A...
Saturday’s 550,000-person protest is the backdrop. Monday’s bonds are the verdict.
Tuesday's Q3 report will force investors to decide what kind of company they actually own.
October 17, 2026 Bonus Content: Teva’s New Schizophrenia Shot Tests Its Branded Pivot A note...
Builder sentiment and housing starts land this week, with the first hard data since Fannie Mae's sharp forecast revision.
Germany’s carrier beat Air France-KLM with a 16% higher all-cash bid, and is now in talks to buy Portugal’s remaining…
With $139.4 billion in Chinese drug licensing deals this year, the question for healthcare investors is who actually owns the…